![his semaglutide D-[His]1-Semaglutide Semaglutide](https://aquigenbio.com/wp-content/uploads/2025/04/d-his1-semaglutide.png)
![his semaglutide D-[His]1-Semaglutide Semaglutide](https://www.bocsci.com/upload/image/18-semaglutide-intermediate-p29-2.jpg)
![his semaglutide D-[His]1-Semaglutide Semaglutide](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=122165575976140741)
![his semaglutide D-[His]1-Semaglutide Semaglutide](https://gizmodo.com/app/uploads/2025/07/ozempic-prep.jpg)
Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Skin Turgor
![his semaglutide D-[His]1-Semaglutide Semaglutide](https://cdn.iris-biotech.de/media/catalog/product/L/S/LS-4040_8.svg)
Retrieved 13 April 2024
![his semaglutide D-[His]1-Semaglutide Semaglutide](https://cdn.prod.website-files.com/68f137dac9caf258fe9bd87e/6939d992febfd6056633b3d6_semaglutide-weight-injections.webp)
Application and Indication Analysis GLP-1 Weight Loss Drug Market by Indication: Obesity Management Commands 61.4% of Revenue While Cardiovascular and Metabolic Indications Drive Premium Expansion GLP-1 Drug Market Revenue Share, CAGR, and Key Clinical Evidence by Application 2026 Obesity and chronic weight management represents the largest GLP-1 drug market application at 61.4% revenue share in 2026
![his semaglutide D-[His]1-Semaglutide Semaglutide](https://noorlasercenter.com/wp-content/uploads/2025/12/semaglutide-info-mobile-6.jpg)
Originally developed for the treatment of type 2 diabetes under the brand name Ozempic , it was later approved by the FDA for chronic weight management in 2021 under the name Wegovy
![his semaglutide D-[His]1-Semaglutide Semaglutide](https://clearsynth.com/clearsynth-packaging-flatbox1.webp)
US$ 28.44
US$ 29.63
US$ 24.17
US$ 20.48
US$ 23.15
